Aspirin Use and Risk of Fatal Cancer

15 Mar 1993Michael J. Thun, Mohan M. Namboodiri, Eugenia E. Calle, W. Dana Flanders and Clark W. Heath Jr.

Data suggest that regular, prolonged use of aspirin may reduce the risk of fatal cancer of the esophagus, stomach, colon, and rectum.

Meta Analysis
4 effects
1982 to 1988
635031 subjects

Reported Outcomes

VariablesOutcomeEffectLatency

Aspirin Manufactured risk & protective factor
Aspirin
Manufactured

Lung cancer Respiratory outcome
Lung cancer
Respiratory

Strong Decrease

Login required to view

Aspirin Manufactured risk & protective factor
Aspirin
Manufactured

Oesophagus cancer Digestive outcome

Strong Decrease

Login required to view

Aspirin Manufactured risk & protective factor
Aspirin
Manufactured

Stomach cancer (Gastric cancer) Digestive outcome

Strong Decrease

Login required to view

Aspirin Manufactured risk & protective factor
Aspirin
Manufactured

Colorectal Cancer Digestive outcome

Strong Decrease

Login required to view